Preliminary CommunicationsHYPERBARIC OXYGENATION IN CHRONIC OSTEOMYELITIS
References (9)
- et al.
Lancet
(1963)Lancet
(1964) - et al.
Lancet
(1964) - et al.
Br. J. Radiotherapy
(1955) Essentials of Orthopædics
(1959)
There are more references available in the full text version of this article.
Cited by (51)
Metronidazole-induced encephalopathy caused by hyperbaric oxygen therapy in a patient with mandibular osteomyelitis
2019, Journal of Infection and ChemotherapyCitation Excerpt :Our case received HBO while using MNZ. HBO is one of the most useful therapeutic options in the treatment of osteomyelitis [14,15]. Its clinical efficacy is explained as follows; modulation of intracellular transduction cascades, leading to synthesis of growth factors and promoting wound healing and ameliorating post-ischemic and post-inflammatory injuries.
Hyperbaric Oxygen: Applications in Infectious Disease
2008, Emergency Medicine Clinics of North AmericaCitation Excerpt :Although this type of trial is preferred, it would be difficult to accomplish, given the relative infrequency of the illness and the varied patient and disease characteristics. Initial evidence for the use of HBO in chronic refractory osteomyelitis first appeared in a paper published in the Lancet in 1965 [48]. There have been numerous studies since then that have argued in favor of HBO.
Microbiology and management of joint and bone infections due to anaerobic bacteria
2008, Journal of Orthopaedic ScienceAdjunctive Hyperbaric Oxygen Therapy in the Treatment of the Diabetic Foot
2008, Levin and O'Neal's: The Diabetic FootHyperbaric Oxygen Therapy in Chronic Osteomyelitis
2008, Physiology and Medicine of Hyperbaric Oxygen TherapyAdjunctive Hyperbaric Oxygen Therapy in the Treatment of the Diabetic Foot
2007, Levin and O'Neal's The Diabetic Foot with CD-ROM
Copyright © 1965 Published by Elsevier Ltd.